title: Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine.
authors.affiliation: Department of Cardiothoracic Surgery, Heart-Lung Transplant Unit, Rabin Medical Center, Beilinson Campus, Israel.
authors.forename: G
authors.initials: G
authors.lastname: Sahar
authors.forename: M
authors.initials: M
authors.lastname: Berman
authors.forename: T
authors.initials: T
authors.lastname: Ben-Gal
authors.forename: E
authors.initials: E
authors.lastname: Sahar
authors.forename: A
authors.initials: A
authors.lastname: Kogan
authors.forename: R
authors.initials: R
authors.lastname: Michowitch
authors.forename: M
authors.initials: M
authors.lastname: Saute
authors.forename: M
authors.initials: M
authors.lastname: Kramer
authors.forename: A
authors.initials: A
authors.lastname: Sagie
authors.forename: Y
authors.initials: Y
authors.lastname: Shapira
authors.forename: D
authors.initials: D
authors.lastname: Aravot
authors.forename: B A
authors.initials: BA
authors.lastname: Vidne
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use*; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus